nucleoside analogs (Chimerix)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenucleoside analogs (Chimerix)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionHepatitis C virus NS5B RNA-dependent RNA polymerase inhibitors
TargetsHepatitis C virus NS5B RNA-dependent RNA polymerase
Therapy Area/IndicationsHepatitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChimerix Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChimerix Inc
Active IndicationsN/A
Inactive IndicationsHepatitis

Other Information

ATC CodeN/A
Related LinksN/A